Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Alcohol Dependence and Binge Eating
NCT00300742Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Mar 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topiramate in alcohol dependence and binge eating disorder (BED), sponsored by University of Virginia. Primary endpoints: Compliance With Study Requirements: Attendance at Treatment Sessions at 12 weeks, Mean Drinks Per Day at Baseline vs. Visit 12 at 24 weeks and 3 more. Started Mar 2006; status: completed.
02
Drugs
topiramate
03
Conditions
alcohol dependencebinge eating disorder (BED)
Beyond the preview
Go deeper on NCT00300742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300742.